Latest filing published 02 Jan 2020 for AIM ImmunoTech Inc., €1,860.
Insider track record
Ellen M. Lintal: trading record in brief
Ellen M. Lintal discloses dealings in AIM ImmunoTech Inc. to SEC (Form 4). In total, 5 filings cover trades dated from 31 October 2019 to 31 December 2019.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 2 January 2020 with a share grant (€1,860) in AIM ImmunoTech Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ellen M. Lintal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,931 shares@ US$0.5319.8% of flowCommon StockSEC:0001450324-20-000003:0
- 4,789 shares@ US$0.43519.9% of flowCommon StockSEC:0001450324-19-000030:0
- 5,208 shares@ US$0.4020.2% of flowCommon StockSEC:0001450324-19-000025:0
- 4,433 shares@ US$0.4720.2% of flowCommon StockSEC:0001450324-19-000020:0
- 4,167 shares@ US$0.5019.9% of flowCommon StockSEC:0001583701-19-000007:0
5 of 5 declarations